Hypertension registry study in Morocco
Part of Heart & circulation clinical trials.
This study is creating a registry of people with high blood pressure in Morocco. It aims to understand different types of hypertension, related health problems, and how to personalize treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have high blood pressure (above 140/90 in a clinic or above 135/85 at home).
- You agree to participate and sign a consent form.
- You have legal residency in Morocco.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This registry collects information from people who have been diagnosed with high blood pressure. It may help researchers better understand who has it and how it’s managed in real life.
This study checks on people who had a heart health screening 10 years ago to learn more about heart risks and develop a risk score just for Moroccans. Researchers will contact you to see how your heart health is now and what might have changed.
This study collects health information to understand how well people with high blood pressure (who take blood pressure medicines) reach their blood pressure targets. It may help improve future guidance on blood pressure monitoring and control.
This study looks at how doctors treat high blood pressure in public health clinics. By reviewing medical records, researchers hope to understand what treatments are used and how well they work.
This study will test a program to help people in Africa better manage their high blood pressure. It is for adults with high blood pressure who are not taking many medicines and have a smartphone.
This trial tests a community-based education program to help people with high blood pressure manage it better. The program uses health beliefs and planning to support lifestyle changes and medication adherence.
Hear when a new Arterial Hypertension trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.